Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris

Inclusion Criteria: * Review and sign statement of Informed Consent and HIPAA authorization. * Males or non-pregnant females ≥ 12 years of age to 17 years, 11 months, of any race or sex. Females of child-bearing potential must have a negative urine pregnancy test. * The parent/legal guardian must complete the informed consent process AND the subject must complete the assent process and sign the appropriate form (if age appropriate). * Presence of tinea cruris characterized by clinical evidence of a tinea infection (at least moderate erythema, moderate scaling, and mild pruritus) based on signs and symptoms. * KOH positive baseline skin scrapings obtained from the site most severely affected or a representative site of the overall severity. * Subjects must be in good health and free from any clinically significant disease that might interfere with the study evaluations. * Subject must be able to understand the requirements of the study and willing to comply with the study requirements. Exclusion Criteria: * A life threatening condition (ex. autoimmune deficiency syndrome, cancer, unstable angina, or myocardial infarction) within the last 6 months. * Subjects with abnormal findings - physical or laboratory - that are considered by the investigator to be clinically important and indicative of conditions that might complicate interpretation of study results.- Severe dermatophytoses, mucocutaneous candidiasis, or bacterial skin infection. * Subjects with a known hypersensitivit…